Shanghai Eye Disease Prevention and Treatment Center

Quick facts

Marketed products

• Atropine Sulfate 0.01% Eye Drop
• Atropine Sulfate 0.04% Eye Drop · Ophthalmology
  Atropine blocks muscarinic acetylcholine receptors in the eye to dilate the pupil and paralyze accommodation.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Shanghai Eye Disease Prevention and Treatment Center portfolio CI brief
• Shanghai Eye Disease Prevention and Treatment Center pipeline updates RSS